News thumbnail
Health / Sat, 29 Aug 2026 Medscape

STAREE Trial: Atorvastatin Cuts Major CV Events by 30% in Older Adults, Driven Mainly by Nonfatal Events - Medscape

STAREE Trial: Atorvastatin Cuts Major CV Events by 30% in Older Adults, Driven Mainly by Nonfatal Events MedscapeStatins can safely cut risk of heart attacks or strokes in healthy people aged over 70, world-first clinical trial shows The GuardianSTAREE: Statins Reduce Cardiovascular Events But Not Disability in Older Adults HCPLiveThis common medication cuts heart attack risk in older people The AgeAtorvastatin reduces major cardiovascular events but misses disability-free survival goal News-Medical

STAREE Trial: Atorvastatin Cuts Major CV Events by 30% in Older Adults, Driven Mainly by Nonfatal Events MedscapeStatins can safely cut risk of heart attacks or strokes in healthy people aged over 70, world-first clinical trial shows The GuardianSTAREE: Statins Reduce Cardiovascular Events But Not Disability in Older Adults HCPLiveThis common medication cuts heart attack risk in older people The AgeAtorvastatin reduces major cardiovascular events but misses disability-free survival goal News-Medical

© All Rights Reserved.